Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
1(25%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
4
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
N/ANon-phased studies
4(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(2)
Other(1)

Detailed Status

Completed2
unknown1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A4 (100.0%)

Trials by Status

unknown125%
completed250%
recruiting125%

Recent Activity

1 active trials
Showing 4 of 4
recruitingnot_applicable

DIALysis With EXpanded Solute Removal

NCT06660277
completednot_applicable

Theranova Versus High-flux Dialyzer on Preservation of Residual Renal Function

NCT04211571
completednot_applicable

Theranova vs High-flux HD Comparison

NCT04106310
unknownnot_applicable

Effect of a Medium Cut-Off Dialyzer - Medical Device on ESA Resistance in 110 Hemodialysis Patients (EXPAND)

NCT03874819

Clinical Trials (4)

Showing 4 of 4 trials
NCT06660277Not Applicable

DIALysis With EXpanded Solute Removal

Recruiting
NCT04211571Not Applicable

Theranova Versus High-flux Dialyzer on Preservation of Residual Renal Function

Completed
NCT04106310Not Applicable

Theranova vs High-flux HD Comparison

Completed
NCT03874819Not Applicable

Effect of a Medium Cut-Off Dialyzer - Medical Device on ESA Resistance in 110 Hemodialysis Patients (EXPAND)

Unknown

All 4 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
4